The Supreme Court has ruled that denying prisoners, including those with disabilities, preferred food items does not violate ...

"Mere non-supply of preferred or costly food items cannot ipso facto be treated as a violation of fundamental rights...The ...

New Delhi, The Supreme Court on Tuesday directed Tamil Nadu jail authorities to identify prisoners with disabilities at the ...

Capricor Therapeutics's dip caused by the CRL is a buying opportunity considering the readout of HOPE-3 within 2-3 months.

The court also underscored that NCRB does not record the disability status of prison inmates but tracks breakup of their caste, gender and religion.

The MESA data demonstrated sustained disease stabilization, reinforcing prior ARCH and CANYON findings. Importantly, CANYON participants w ...

Capricor receives FDA Orphan Drug Designation for Deramiocel, targeting Becker Muscular Dystrophy while advancing Duchenne Muscular Dystrophy application.

Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today unveiled positive results in its sevasemten program for Becker and Duchenne muscular dystrophies.

Becker Muscular Dystrophy, like Duchenne Muscular Dystrophy (DMD), is a progressive X-linked neuromuscular disorder that results in significant skeletal and cardiac muscle deterioration over time.

The FDA rejected a Duchenne muscular dystrophy cell therapy from Capricor Therapeutics, as a larger study of the treatment ...

The Supreme Court Tuesday said prisoners, including disabled ones, not being provided “preferred or costly food items” in ...

U.S. FDA grants Orphan Drug Designation to Deramiocel for the treatment of Becker Muscular Dystrophy, broadening Capricor’s focus in neuromuscular diseasesCapricor remains on track for the ...